The MMR vaccine is a combination shot that protects against three viral infections: measles, mumps, and rubella (sometimes called German measles). It uses weakened, live versions of each virus to train your immune system to recognize and fight the real thing. Two doses, given in childhood, provide 97% protection against measles, 86% against mumps, and 97% against rubella.
The Three Diseases It Prevents
Measles, mumps, and rubella were once extremely common childhood illnesses, and all three can cause serious complications. Measles spreads through the air and is one of the most contagious diseases known. A single infected person can spread it to a dozen others in any community where less than 95% of people are vaccinated. Complications include pneumonia, brain swelling (encephalitis), and death, particularly in young children and those with weakened immune systems.
Mumps causes painful swelling of the salivary glands near the jaw, along with fever, headache, and muscle aches. In some cases it leads to deafness, meningitis, or swelling of the brain, ovaries, or testicles. Rubella is typically milder, with a rash and low-grade fever, but it poses a severe threat during pregnancy. A rubella infection in the first trimester can cause miscarriage, stillbirth, or a constellation of birth defects including heart problems, hearing loss, and intellectual disability.
How the Vaccine Works
The MMR vaccine contains live but significantly weakened (attenuated) versions of all three viruses. These weakened viruses can’t cause the actual diseases, but they’re similar enough to trigger a full immune response. Your body produces antibodies and memory cells that remain on standby, ready to neutralize the real viruses if you’re ever exposed. This approach tends to produce strong, long-lasting immunity, often for life after the complete two-dose series.
Recommended Schedule
Children receive two doses. The first is given between 12 and 15 months of age, and the second between 4 and 6 years. The minimum gap between doses is 28 days, though most children follow the standard schedule spaced years apart.
Teens and adults who never received the vaccine, or who aren’t sure of their vaccination history, can still get caught up. Adults generally need at least one dose, with a second dose recommended for those at higher risk, such as college students, healthcare workers, and international travelers. During a mumps outbreak, a third dose may be recommended for people in affected communities.
How Effective Each Dose Is
Protection improves significantly with the second dose. After one dose, the vaccine is 93% effective against measles, 72% effective against mumps, and 97% effective against rubella. After two doses, measles protection rises to 97% and mumps protection to 86%. Mumps effectiveness is notably lower than the other two, which is why outbreaks still occasionally occur in vaccinated populations, particularly in close-contact settings like college dormitories.
Communities need at least 95% vaccination coverage with both doses to prevent measles outbreaks. This high threshold exists because measles is extraordinarily contagious. When coverage dips below that level, even briefly, outbreaks can take hold quickly.
Common Side Effects
Most side effects are mild and short-lived. The most common include a sore arm at the injection site, a low-grade fever, and a mild rash. Some people develop temporary swelling in the cheeks or neck. These reactions typically appear within the first week or two and resolve on their own.
Joint pain and stiffness are more specific to the rubella component of the vaccine. Up to 1 in 4 women past puberty who weren’t previously immune to rubella experience temporary joint symptoms, usually starting one to three weeks after the shot and lasting about two days. This is much less common in children and men.
Rare Side Effects
Febrile seizures, which are seizures triggered by a rapid rise in body temperature, occur in roughly 1 in 3,000 to 4,000 vaccinated children under age 7. These typically happen 6 to 14 days after the shot. While frightening to witness, febrile seizures are generally not harmful and don’t cause lasting effects.
A temporary drop in platelet count (the blood cells that help with clotting) occurs in about 1 in 40,000 vaccinated children within six weeks of the shot. This condition, called immune thrombocytopenic purpura, can cause easy bruising or bleeding but usually resolves without treatment. Severe allergic reactions are possible but rare.
MMR vs. MMRV
For children between 12 months and 12 years old, there’s also an MMRV vaccine, which adds protection against varicella (chickenpox) to the standard MMR. The advantage is one fewer shot at the doctor’s visit. The tradeoff is a slightly higher rate of fever and febrile seizures after the first dose. About 22 out of 100 children who receive MMRV develop a fever of 102°F or higher, compared to about 15 out of 100 who get MMR and varicella as separate shots. The risk of febrile seizures roughly doubles with MMRV during the first dose (about 8 per 10,000 children versus 4 per 10,000).
This increased risk applies mainly to the first dose in children under 4. By the second dose, MMRV is less likely to cause fever, and children aged 4 to 6 don’t appear to have a higher seizure risk with the combination vaccine. Children with a personal or family history of seizures are generally given MMR and varicella as separate shots instead of MMRV.
Who Should Not Get the MMR Vaccine
Because the vaccine contains live viruses, certain groups should avoid it. Pregnant women should not receive MMR due to the theoretical risk to the fetus. Women who aren’t immune to rubella are recommended to get vaccinated immediately after giving birth. People with severe immune deficiencies, whether from conditions like cancer, chemotherapy, or long-term immunosuppressive medications, should also avoid it. However, people living with HIV who are not severely immunosuppressed can safely receive the vaccine.
Other contraindications include a history of severe allergic reaction to a previous dose or to any component of the vaccine, and a history of a platelet disorder called thrombocytopenic purpura. If you’ve recently received a blood product containing antibodies (such as a transfusion or immune globulin), you may need to wait up to 11 months before getting the MMR, depending on the specific product.
The Autism Claim Has Been Thoroughly Debunked
A 1998 paper published in The Lancet by Andrew Wakefield claimed a link between the MMR vaccine and autism, based on just 12 children. The paper fueled widespread vaccine hesitancy for years. It was fully retracted in 2010 after an investigation by Britain’s General Medical Council found that Wakefield had carefully selected his subjects rather than studying consecutive cases, that some of his research was funded by lawyers pursuing lawsuits against vaccine manufacturers, and that he had shown “callous disregard” for the children in his study by performing invasive, unnecessary tests on them.
No large study has ever replicated Wakefield’s findings. Multiple studies involving millions of children across several countries have found no connection between the MMR vaccine and autism. The scientific consensus is clear: autism has a genetic basis with environmental factors that researchers are still working to understand, but the MMR vaccine is not among them.